These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 2529358

  • 1. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ, First MR, Hurtubise PE, Marmer DJ, Martin DM, Mansour ME, Melvin DB.
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [Abstract] [Full Text] [Related]

  • 2. Successful retreatment of allograft rejection with OKT3.
    First MR, Schroeder TJ, Hurtubise PE, Mansour ME, Penn I, Munda R, Balistreri WF, Alexander JW, Melvin DB, Fidler JP.
    Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients.
    Schroeder TJ, First MR, Mansour ME, Alexander JW, Penn I.
    Am J Kidney Dis; 1989 Nov; 14(5 Suppl 2):14-8. PubMed ID: 2510506
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Failure of orthoclone OKT3 retreatment in a pancreas transplant recipient with antimurine antibodies.
    Schroeder TJ, Munda R, Pedersen SH, Hurtubise PE, Alexander JW, First MR.
    J Clin Lab Anal; 1990 Nov; 4(2):99-101. PubMed ID: 2313476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG, O'Connell JB, Gilbert EM, Hammond ME, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM.
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [Abstract] [Full Text] [Related]

  • 11. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP, Frazier OH, Lammermeier D, Radovancevic B, Duncan JM.
    J Heart Transplant; 1989 Apr; 8(4):281-7. PubMed ID: 2504894
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience.
    Costanzo-Nordin MR, O'Sullivan EJ, Hubbell EA, Zucker MJ, Pifarre R, McManus BM, Winters GL, Scanlon PJ, Robinson JA.
    J Heart Transplant; 1989 Apr; 8(4):288-95. PubMed ID: 2504895
    [Abstract] [Full Text] [Related]

  • 13. Reexposure to OKT3 in renal allograft recipients.
    Mayes JT, Thistlethwaite JR, Stuart JK, Buckingham MR, Stuart FP.
    Transplantation; 1988 Feb; 45(2):349-53. PubMed ID: 3278428
    [Abstract] [Full Text] [Related]

  • 14. Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.
    Goldstein G.
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):1-6. PubMed ID: 3105134
    [No Abstract] [Full Text] [Related]

  • 15. Mouse antibody-coated lymphocytes during OKT3 therapy in liver transplantation.
    Broughan TA, Valenzuela R, Escorcia E, Secic M, Vogt DP.
    Clin Transplant; 1994 Oct; 8(5):488-91. PubMed ID: 7819617
    [Abstract] [Full Text] [Related]

  • 16. The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells.
    Caillat-Zucman S, Blumenfeld N, Legendre C, Noel LH, Bach JF, Kreis H, Chatenoud L.
    Transplantation; 1990 Jan; 49(1):156-60. PubMed ID: 2137271
    [Abstract] [Full Text] [Related]

  • 17. An overview of the use of the monoclonal antibody OKT3 in renal transplantation.
    Norman DJ.
    Transplant Proc; 1988 Dec; 20(6):1248-52. PubMed ID: 2974204
    [Abstract] [Full Text] [Related]

  • 18. OKT3 resistant rejection in liver transplant patients.
    Sutherland F, Lazarovits A, Aboujaoude M, Grant D, Ghent C, Sommerauer J, Wall W.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1413-4. PubMed ID: 1824898
    [No Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR, Barry JM, Alexander SR, Melvin T, Striegel J, Reller K, Henell KR, Kimball J, Funnell MB, Goldstein G.
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [Abstract] [Full Text] [Related]

  • 20. The incidence of antibody formation to OKT3 consequent to its use in organ transplantation.
    Carey G, Lisi PJ, Schroeder TJ.
    Transplantation; 1995 Jul 27; 60(2):151-8. PubMed ID: 7624957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.